- Home
- TLSI vs MMT Comparison
TLSI vs MMT Comparison
Compare TLSI & MMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLSI | MMT |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | United States |
| Employees | 110 | N/A |
| Industry | Medical Specialities | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.1M | 255.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSI | MMT |
|---|---|---|
| Price | $4.16 | $4.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 198.2K | 81.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.58% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.30 |
| Revenue | N/A | N/A |
| Revenue This Year | $41.93 | N/A |
| Revenue Next Year | $41.75 | N/A |
| P/E Ratio | ★ N/A | $15.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.42 | $4.31 |
| 52 Week High | $7.95 | $4.87 |
Technical Indicators
Market Signals| Indicator | TLSI | MMT |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 35.97 |
| Support Level | $3.61 | $4.60 |
| Resistance Level | $5.51 | $4.68 |
| Average True Range (ATR) | 0.39 | 0.03 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 7.22 | 37.31 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MMT MFS Multimarket Income Trust
MFS Multimarket Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests a majority of its net assets in fixed-income securities, corporate bonds of the U.S and foreign issuers, U.S Government securities, foreign government securities, mortgage-backed and other asset-backed securities of U.S and foreign issuers, and debt instruments of issuers located in emerging market countries. The portfolio of investments comprises of different sector investments such as aerospace, airlines, automotive, chemicals, electronics, and others.